Additionally, AD patients have exhibited higher levels of pro-inflammatory cytokines such as NLRP3, CXCL2, IL-6, and IL-1β in plasma samples, along with the activation of asparagine endopeptidase (AEP), which is associated with neuroinflammation. This evidence concerns the gene LGMN and Alzheimer disease.